Huma Q. Rana, MD, MPH is the Clinical Director of the Division of Cancer Genetics and Prevention at Dana-Farber Cancer Institute, and Assistant Professor of Medicine at Harvard Medical School.

At Dana-Farber and its regional campuses, Dr. Rana oversees the medical management and the clinical operations that provide care to individuals with genetic susceptibility to cancer.

In addition to her clinical work, Dr. Rana leads multiple research studies focused on defining cancer genetic phenotype-genotype associations to inform the development of cancer prevention and screening. She also studies novel approaches to genetic testing in an effort improve access to cancer genetics services among diverse patient populations.

Dr. Rana received her medical degree from the Rutgers Robert Wood Johnson Medical School, completed her residencies in Internal Medicine and Clinical Genetics at the Icahn School of Medicine at Mount Sinai, and received her MPH from the Harvard T.H. Chan School of Public Health.